Abstract
Burada 8 aylık bir çocukta piridoksin ve piridostigmin tedavisi ile düzenlenen vinkristin ilişkili bir kraniyal polinöropati olgusunu sunduk. 8 aylık kız hastada pre B cell ALL tanısı kondu. Hastaya ALL St Jude TXIII tedavi protokolü başlandı. Dördüncü vinkristin dozunda 20 gün sonra pitozis gelişti. Nörolojik muayenede pupiller ve korneal refleksler normaldi. Pitozis gelişmeden önce total 2.8 mg vinkristin almıştı. Nöroprotektif ve nörorejenaratif tedavi olarak piridoksin ve piridostigmin başlandı. Pitozis 6 gün içinde düzelmeye başladı ve 2 hafta içinde tamamen iyileşti. Tedavi 3haftaya tamamlandı ve herhangi bir yan etki görülmedi. Takipte pitozis tekrar etmedi.
Keywords
References
- Quasthoff S, Hartung HP. Chemotherapy-induced peripheral neu- ropathy. J Neurol 2002; 249: 9-17.
- Legha SS. Vincristine neurotoxicity. Pathophysiology and mana- gement. Med Toxicol 1986; 1 : 421-427.
- Bay A, Yilmaz C, Yilmaz N, Oner AF. Vincristine induced cranial polyneuropathy. Indian J Pediatr 2006; 73 : 531-533.
- Ann Pharmacother 2000; 34 : 1136-1138.
- Chan JD. Pharmacokinetic drug interactions of vinca alkaloids: summary of case reports. Pharmacotherapy 1998; 18 : 1304-1307.
- . Pediatr Blood Cancer 2004; 42 : 287-288.
- Jackson DV, Jr., Pope EK, McMahan et RA Cooper MR, Atkinsın, Callahan RD, Paschold EM, Grimm RA, Hopunins 10, Muss HB. Clinical trial of pyridoxine to reduce vincristine neurotoxicity. J Neurooncol 1986; 4 : 37-41.
Abstract
İn this poper we described an 8-month-old girl with vincristine induced cranial polyneuropathy who was succesfully treated with pyridoxine and pyridostigmine. The patient was diagnosed as preB cell ALL and received chemotherapy according to the previously described St. Jude total therapy XIII studies. Twenty days after the fourth dose of vincristine (cumulative dose 2.8 mg), she developed ptosis. Neurological examination revealed ptosis with normal pupillary and corneal reflexes. Pyridoxine and pyridostigmine was initiated as an attempt for neuroprotection and neuroregeneration. Ptosis markedly improved after 6 days and completely resolved after two weeks. Both agents were given for 3 weeks and were well tolerated without any side effects. During the follow up period we did not observe residue recurrence of ptosis
Keywords
References
- Quasthoff S, Hartung HP. Chemotherapy-induced peripheral neu- ropathy. J Neurol 2002; 249: 9-17.
- Legha SS. Vincristine neurotoxicity. Pathophysiology and mana- gement. Med Toxicol 1986; 1 : 421-427.
- Bay A, Yilmaz C, Yilmaz N, Oner AF. Vincristine induced cranial polyneuropathy. Indian J Pediatr 2006; 73 : 531-533.
- Ann Pharmacother 2000; 34 : 1136-1138.
- Chan JD. Pharmacokinetic drug interactions of vinca alkaloids: summary of case reports. Pharmacotherapy 1998; 18 : 1304-1307.
- . Pediatr Blood Cancer 2004; 42 : 287-288.
- Jackson DV, Jr., Pope EK, McMahan et RA Cooper MR, Atkinsın, Callahan RD, Paschold EM, Grimm RA, Hopunins 10, Muss HB. Clinical trial of pyridoxine to reduce vincristine neurotoxicity. J Neurooncol 1986; 4 : 37-41.
Details
| Other ID | JA74NG64NT |
|---|---|
| Journal Section | Case Report |
| Authors | |
| Publication Date | April 1, 2007 |
| Submission Date | April 1, 2007 |
| Published in Issue | Year 2007 Volume: 1 Issue: 2 |
The publication language of Turkish Journal of Pediatric Disease is English.
Manuscripts submitted to the Turkish Journal of Pediatric Disease will go through a double-blind peer-review process. Each submission will be reviewed by at least two external, independent peer reviewers who are experts in the field, in order to ensure an unbiased evaluation process. The editorial board will invite an external and independent editor to manage the evaluation processes of manuscripts submitted by editors or by the editorial board members of the journal. The Editor in Chief is the final authority in the decision-making process for all submissions. Articles accepted for publication in the Turkish Journal of Pediatrics are put in the order of publication, with at least 10 original articles in each issue, taking into account the acceptance dates. If the articles sent to the reviewers for evaluation are assessed as a senior for publication by the reviewers, the section editor and the editor considering all aspects (originality, high scientific quality and citation potential), it receives publication priority in addition to the articles assigned for the next issue.
The aim of the Turkish Journal of Pediatrics is to publish high-quality original research articles that will contribute to the international literature in the field of general pediatric health and diseases and its sub-branches. It also publishes editorial opinions, letters to the editor, reviews, case reports, book reviews, comments on previously published articles, meeting and conference proceedings, announcements, and biography. In addition to the field of child health and diseases, the journal also includes articles prepared in fields such as surgery, dentistry, public health, nutrition and dietetics, social services, human genetics, basic sciences, psychology, psychiatry, educational sciences, sociology and nursing, provided that they are related to this field. can be published.